
Progyny (PGNY) Stock Forecast & Price Target
Progyny (PGNY) Analyst Ratings
Bulls say
Progyny Inc. has demonstrated strong performance in its egg retrieval and banking services, with a record 39% year-over-year increase, driven by heightened demand among women in the tech industry amid economic uncertainties. The company's anticipated standardization of coverage packages for fertility benefits is expected to yield incremental revenue opportunities, particularly as more states implement IVF mandates. Additionally, robust client retention rates near 100% and an increase in covered lives accessing ancillary services from 1.5 million in 2025 to 2.7 million in 2026 further solidify Progyny's growth potential and positive outlook for future financial performance.
Bears say
Progyny Inc. is facing significant headwinds due to ongoing economic uncertainty and a weak jobs market, which may deter potential clients from utilizing its fertility and pharmacy benefit offerings. Furthermore, the company's reduction in expected covered lives from 7.6 million to 7.2 million combined with lower adjusted EBITDA guidance—ranging from $224 to $239 million—suggests a decline in revenue potential that does not meet previous estimates. Additionally, the competitive landscape presents challenges for maintaining market share, as underperformance could adversely affect the company's overall operational results.
This aggregate rating is based on analysts' research of Progyny and is not a guaranteed prediction by Public.com or investment advice.
Progyny (PGNY) Analyst Forecast & Price Prediction
Start investing in Progyny (PGNY)
Order type
Buy in
Order amount
Est. shares
0 shares